Brief: Iovance Biotherapeutics Inc Files For Mixed Shelf
18/06/2026 23:37
BRIEF-Iovance Biotherapeutics Inc Files For Mixed Shelf June 18 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:
IOVANCE BIOTHERAPEUTICS INC FILES FOR MIXED SHELF - SEC FILING
IOVANCE BIOTHERAPEUTICS INC: SALE AGREEMENT PROSPECTUS SUPPLEMENT COVERING OFFERING OF UP TO $89.7 MILLION COMMON STOCK
Source text: [ID:n0001104659-26-075778]
Further company coverage: IOVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies